Immunic, Inc. (IMUX)
15.40
-0.90
(-5.52%)
USD |
NASDAQ |
Aug 28, 16:00
15.40
0.00 (0.00%)
After-Hours: 20:00
Immunic Cash and Short Term Investments (Quarterly) : 155.10M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 155.10M |
| March 31, 2026 | 186.63M |
| December 31, 2025 | 15.48M |
| September 30, 2025 | 35.13M |
| June 30, 2025 | 55.31M |
| March 31, 2025 | 14.30M |
| December 31, 2024 | 35.67M |
| September 30, 2024 | 59.07M |
| June 30, 2024 | 79.70M |
| March 31, 2024 | 97.31M |
| December 31, 2023 | 46.67M |
| September 30, 2023 | 59.69M |
| June 30, 2023 | 77.29M |
| March 31, 2023 | 97.11M |
| December 31, 2022 | 116.37M |
| September 30, 2022 | 72.77M |
| June 30, 2022 | 88.08M |
| March 31, 2022 | 95.71M |
| December 31, 2021 | 86.86M |
| September 30, 2021 | 110.44M |
| June 30, 2021 | 87.18M |
| March 31, 2021 | 114.84M |
| December 31, 2020 | 127.45M |
| September 30, 2020 | 133.18M |
| June 30, 2020 | 48.61M |
| Date | Value |
|---|---|
| March 31, 2020 | 18.58M |
| December 31, 2019 | 29.37M |
| September 30, 2019 | 30.46M |
| June 30, 2019 | 36.12M |
| March 31, 2019 | 9.595M |
| December 31, 2018 | 13.07M |
| September 30, 2018 | 17.80M |
| June 30, 2018 | 31.12M |
| March 31, 2018 | 43.65M |
| December 31, 2017 | 56.90M |
| September 30, 2017 | 66.39M |
| June 30, 2017 | 76.15M |
| March 31, 2017 | 86.64M |
| December 31, 2016 | 59.99M |
| September 30, 2016 | 68.11M |
| June 30, 2016 | 73.84M |
| March 31, 2016 | 78.20M |
| December 31, 2015 | 83.95M |
| September 30, 2015 | 60.82M |
| June 30, 2015 | 73.36M |
| March 31, 2015 | 89.79M |
| December 31, 2014 | 103.83M |
| September 30, 2014 | 80.55M |
| June 30, 2014 | 92.07M |
| March 31, 2014 | 47.05M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Sionna Therapeutics, Inc. | 211.03M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |
| Savara, Inc. | 173.03M |